Moreover, hypoglycaemia and weight gain [42] were closely associated with insulin therapy in T2D patients, in which the lower FBG target may lead to an insulin dose increase in T2D patients, which was a risk factor for hypoglycaemia and weight gain. Here, INS is linked to type 2 diabetes mellitus.